USPTO serial 79338320
RESET MIND SCIENCES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 31, 2023
- Examiner
- BEN, LINDSEY HEATHER
- Law office
- TMEG LAW OFFICE 108
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with RESET MIND SCIENCES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christopher J. Schulte
Christopher J. Schulte Merchant & Gould, P.C.P.O. BOX 2910Minneapolis, MN 55402-0910UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical compositions for treating disorders of the brain, depressive illness, anxiety and mood disorders, personality disorders, post-traumatic stress disorder, and substance addiction; [ chemical, ] pharmaceutical [ and therapeutic ] agents for treating disorders of the brain, depressive illness, anxiety and mood disorders, personality disorders, post-traumatic stress disorder, and substance addiction; infusions for medicinal purposes made from herbs; medicinal herbs; herbal preparations for medical purposes; pharmaceutical preparations for human use for treating disorders of the brain, depressive illness, anxiety and mood disorders, personality disorders, post-traumatic stress disorder, and substance addiction; pharmaceutical preparations for health care for treating disorders of the brain, depressive illness, anxiety and mood disorders, personality disorders, post-traumatic stress disorder, and substance addiction; pharmaceutical preparations for nasal use for treating disorders of the brain, depressive illness, anxiety and mood disorders, personality disorders, post-traumatic stress disorder, and substance addiction; pharmaceutical preparations for oral use for treating disorders of the brain, depressive illness, anxiety and mood disorders, personality disorders, post-traumatic stress disorder, and substance addiction; pharmaceutical preparations for topical use for treating disorders of the brain, depressive illness, anxiety and mood disorders, personality disorders, post-traumatic stress disorder, and substance addiction; pharmaceutical preparations for treating disorders of the brain, depressive illness, anxiety and mood disorders, personality disorders, post-traumatic stress disorder, and substance addiction in the form of foams, gels, emulsions, elixirs, lotions, ointments, tinctures, creams, liquids, oils, lozenges, tablets, capsules, sprays and skin patches; pharmaceutical preparations and substances for the prevention, management and treatment of disorders of the brain, depressive illness, anxiety and mood disorders, personality disorders, post-traumatic stress disorder, substance addiction | ACTIVE | — |
| 042 | Pharmaceutical research services; research relating to pharmaceuticals; pharmaceutical research services for assessing the efficiency of pharmaceuticals; pharmaceutical research services for assessing the safety of pharmaceuticals; scientific research in the nature of conducting clinical trials for others [ ; sponsoring scientific research in the nature of conducting clinical trials for others ] | ACTIVE | — |
| 044 | Health and medical consultancy, advisory and information services relating to pharmaceuticals *, namely, psychedelic preparations * ; provision of health and medical clinics * for the prevention, management and treatment of disorders using psychedelic preparations * ; arranging and provision of medical treatment * for the prevention, management and treatment of disorders using psychedelic preparations; none of the aforementioned services being for or related to weight management programs * | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LGP Alternative Therapies Pty Ltd
- Other trademarks owned by LGP Alternative Therapies Pty Ltd
- Other trademarks owned by Reset Mind Sciences Limited
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named RESET MIND SCIENCES
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 24, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 7, 2024 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Oct 17, 2024 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 11, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 16, 2024 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Feb 15, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 15, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 15, 2024 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Feb 15, 2024 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Jan 31, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 10, 2023 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Oct 31, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 31, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 28, 2023 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 9, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 20, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Sep 20, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 15, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 15, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 14, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 26, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 26, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 26, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 10, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 8, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 7, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 7, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 14, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 24, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 24, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 18, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 17, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 7, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 19, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 15, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 14, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |